R&D/Clinical Trials

>

Latest News

Statistically and Clinically Significant Paths to Value Proposition
Statistically and Clinically Significant Paths to Value Proposition

February 12th 2025

Demonstrating clinical benefit is the ultimate gateway to smoother patient access.

Gen Li
The Most Studied Diseases in a Post-Covid World: Q&A with Gen Li

February 11th 2025

Mim8 Demonstrates Promising Results in Pediatric Patients with Hemophilia A
Mim8 Demonstrates Promising Results in Pediatric Patients with Hemophilia A

February 10th 2025

Merck Launches Phase III Trial Evaluating Zilovertamab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Merck Launches Phase III Trial Evaluating Zilovertamab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

February 6th 2025

ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer
ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer

January 30th 2025

More News